RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.08B
AUM Growth
-$217M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
68
New
Increased
Reduced
Closed

Top Buys

1
+$174M
2
+$103M
3
+$74.5M
4
TSHA icon
Taysha Gene Therapies
TSHA
+$58.4M
5
APGE icon
Apogee Therapeutics
APGE
+$42.1M

Top Sells

1
+$365M
2
+$47.4M
3
+$30.3M
4
DSGN icon
Design Therapeutics
DSGN
+$18.7M
5
CVAC icon
CureVac
CVAC
+$11.2M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$13.2M 0.26%
6,144,881
52
$12.8M 0.25%
1,400,001
53
$11.1M 0.22%
+1,246,667
54
$10.8M 0.21%
7,805,129
55
$10.1M 0.2%
3,525,754
56
$9.52M 0.19%
+1,286,000
57
$8.63M 0.17%
3,426,286
58
$7.83M 0.15%
937,500
59
$6.75M 0.13%
240,324
+7,006
60
$6.24M 0.12%
+6,501,624
61
$6.15M 0.12%
+961,863
62
$5.73M 0.11%
6,991,003
63
$2.98M 0.06%
+347,069
64
$2.96M 0.06%
1,723,373
65
$1.59M 0.03%
+342,000
66
$633K 0.01%
333,333
67
– –
-2,971,231
68
– –
-7,856,612
1 2
3